Targeted therapy of human laryngeal squamous cell carcinoma in vitro by antisense oligonucleotides directed against telomerase reverse transcriptase mRNA

Journal of Laryngology and Otology

Volumn 119, Issue 2, 2005, Pages 92-96

  Tao, Zezhang ^a   Chen, Shiming ^a   Wu, Zhanyuan ^a   Xiao, Bokui ^a   Liu, Jianfeng ^a   Hou, Wei ^b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Antisense oligonucleotide; Larynx; Squamons Cell Carcinoma; Telomerase

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; MESSENGER RNA; RNA DIRECTED DNA POLYMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LARYNX CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA;

APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; DNA-BINDING PROTEINS; DOWN-REGULATION; GENE TARGETING; GENE THERAPY; HUMANS; LARYNGEAL NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; RNA, NEOPLASM; TELOMERASE;

EID: 15244343405     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1258/0022215053419943     Document Type: Article

References (30)

1. Masutomi K, Yu EY, Khurs S, Ben-Porath I, Currier JL, Metz GB, et al. Telomerase maintains telomere structure in normal human cells. Cell 2003;114:241-53
2. Smolikov S, Mazor Y, Krauskopf A. ELG1, a regulator of genome stability, has a role in telomere length regulation and in silencing. Proc Natl Acad Sci USA 2004; 101:1656-61
3. Stewart SA. Multiple levels of telomerase regulation. Mol Interv 2002;2:481-3
4. Boldrini L, Faviana P, Gisfredi S, Donati V, Zucconi Y, Ursino S, et al. Regulation of telomerase and its hTERT messenger in colorectal cancer. Oncol Rep 2004;11:395-400
5. Guilleret I, Benhattar J. Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. Exp Cell Res 2003;289:326-34
6. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349-52
7. Simonsen JL, Rosada C, Serakinci N, Justesen J, Stenderup K, Rattan SI, et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol 2002;20:592-6
8. Tao ZZ, Liu JF, Xiao BK. Telomerase activity in human head and neck squamous cell carcinoma and adjacent tissues. Chinese Cancer 2000;19:671-3
9. Luzar B, Poljak M, Marin IJ, Fischinger J, Gale N. Quantitative measurement of telomerase catalytic subunit (hTERT) RNA in laryngeal squamous cell carcinomas. Anticancer Res 2001;21:4011-55
10. Curran AJ, Gullane PJ, Irish J, Macmillan C, Freeman J, Kamel-Reid S. Telomerase activity is upregulated in laryngeal squamous cell carcinoma. Laryngoscope 2000;110:391-6
11. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 1997;17:498-502
12. Kushner DM, Paranjape JM, Bandyopadhyay B, Cramer H, Leaman DW, Kennedy AW, et al. 2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells. Gynecol Oncol 2000;76:183-93
13. Xu D, Gruber A, Peterson C, Pisa P. Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. Br J Haematol 1998;102:1367-75
14. Xu D, Gruber A, Peterson C, Pisa P. Supression of telomerase activity in HL60 cells after treatment with differentiating agents. Leukemia 1996;10:1354-7
15. Lehner R, Enomoto T, McGregor JA, Shroyer AL, Haugen BR, Pugazhenthi U, et al. Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium. Gynecol Oncol 2002;84:120-5
16. Kim NW. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;226:2011-5
17. Bai Y, Murnane JP. Telomere instability in a human tumour cell line expressing NBS1 with mutations at sites phosphorylated by ATM. Mol Cancer Res 2003;1:1058-69
18. Meeker AK, Hicks JL, Gabrielson E, Strauss WM, De Marzo AM, Argani P. Telomere shortening occurs in subsets of normal breast epithelium as well as in situ and invasive carcinoma. Am J Pathol 2004;164:925-35
19. Kondo S, Kondo Y, Li GY, Silverman RH, Cowell JK. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene 1998;16:3323-30
20. Yatabe N, Kyo S, Kondo S, Kanaya T, Wang Z, Maida Y, et al. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells. Cancer Gene Ther 2002;9:624-30
21. Volavsek M, Bracko M, Gale N. Distribution and prognostic significance of cell cycle proteins in squamous carcinoma of the larynx, hypopharynx and adjacent epithelial hyperplastic lesions. J Laryngol Otol 2003;117:286-93
22. Krecicki T, Jelen M. Proliferating cell nuclear antigen in laryngeal cancer. J Laryngol Otol 1998;112:310-13
23. Wang J, Xie LY, Allan S, Beach D, Hannon GJ. Myc activates telomerase Gene Dev 1998;12:1769-74
24. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, et al. Direct activation of TERT transcription by c-MYC. Nat Genet 1999;21:220-4
25. Veldman T, Liu X, Yuan H, Schlegel R. Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc Natl Acad Sci USA. 2003; 100:8211-16
26. Wu X, Kemp B, Amos CI, Honn SE, Zhang W, Walsh GL, et al. Associations among telomerase activity, P53 protein overpression, and genetic instability in lung cancer. Br J Cancer 1999;80:453-7
27. Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, et al. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 2000;28:669-77
28. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998;18:65-8
29. Poole JC, Andrews LG, Tollefsbol TO. Activity, function, and gene regulation of catalytic subunit of telomerase (hTERT) Gene 2001;269:1-12
30. Horikawa I, Barrett JC. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 2003;24:1167-76